Viewing StudyNCT06210971



Ignite Creation Date: 2024-05-06 @ 8:00 PM
Last Modification Date: 2024-10-26 @ 3:18 PM
Study NCT ID: NCT06210971
Status: RECRUITING
Last Update Posted: 2024-01-18
First Post: 2024-01-07

Brief Title: Neoadjuvant Chemoradiation With Nal-IRI and Capecitabine Guided by UGT1A1 Status in Patients With Rectal Cancer
Sponsor: Hebei Medical University Fourth Hospital
Organization: Hebei Medical University Fourth Hospital

Key Dates - Follows AllAPIJSON File Order

Start Date: 2024-02-01
Start Date Type: ESTIMATED
Primary Completion Date: 2026-02-01
Primary Completion Date Type: ESTIMATED
Completion Date: 2028-07-01
Completion Date Type: ESTIMATED
First Submit Date: 2024-01-07
First Submit QC Date: January 7 2024
Study First Post Date: 2024-01-18
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-08-13
Last Update Post Date: 2024-01-18
Last Update Post Date Type: ACTUAL